NetraMark Holdings Inc. (TSX:AIAI)
Canada · Delayed Price · Currency is CAD 0.9200
+0.0600 (6.98%)
At close: Jul 10, 2026
NetraMark Holdings Revenue
NetraMark Holdings had revenue of 10.58K CAD in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 175.85K, down -71.65% year-over-year. In the fiscal year ending September 30, 2025, NetraMark Holdings had annual revenue of 432.50K, down -5.18%.
Revenue (ttm)
175.85K
Revenue Growth
-71.65%
P/S Ratio
485.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
85.33M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 432.50K | -23.63K | -5.18% |
| Sep 30, 2024 | 456.13K | 366.86K | 410.97% |
| Sep 30, 2023 | 89.27K | -23.76K | -21.02% |
| Sep 30, 2022 | 113.03K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitalhub | 119.20M |
| Victory Square Technologies | 55.78M |
| Hydreight Technologies | 55.78M |
| NexgenRx | 18.45M |
| Comprehensive Healthcare Systems | 5.94M |
| KDA Group | 419.13K |
| Principal Technologies | 370.42K |
| DIAGNOS | 65.48K |
NetraMark Holdings News
- 3 days ago - NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner - GlobeNewsWire
- 13 days ago - NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company - GlobeNewsWire
- 4 weeks ago - NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026 - GlobeNewsWire
- 7 weeks ago - NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting - GlobeNewsWire
- 2 months ago - NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum - GlobeNewsWire
- 2 months ago - NetraMark Announces Change To Board Of Directors - GlobeNewsWire
- 2 months ago - NetraMark Holdings Inc. (AIAI) Opens the Market - Newsfile Corp
- 2 months ago - NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI - GlobeNewsWire